Based on 6 Wall Street analysts offering 12 month price targets for Nektar Therapeutics in the last 3 months. The average price target is $2.75 with a high forecast of $6.00 and a low forecast of $1.00. The average price target represents a 308.07% change from the last price of $0.67.
Comment
⋅
I started selling NKTR shares from 0.8 and completely out at 0.95; it's time to slowly buy the upcoming intraday dips.